BPTF promotes the progression of distinct subtypes of breast cancer and is a therapeutic target

PurposeTo assess the biomarker and functional role of the chromatin remodeling factor, bromodomain PHD finger transcription factor (BPTF), in breast cancer progression.MethodsBPTF copy number was assessed using fluorescence in situ hybridization. BPTF expression was regulated in breast cancer cells...

Descripció completa

Dades bibliogràfiques

Autors principals:	Vladimir Bezrookove, Imran A. Khan, Mehdi Nosrati, James R. Miller, Sean McAllister, Altaf A. Dar, Mohammed Kashani-Sabet
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2022-11-01
Col·lecció:	Frontiers in Oncology
Matèries:	BPTF triple-negative ER-positive breast cancer oncogene
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1011173/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!